Arkolith/Insider Trading/SMMT/Form 4

Duggan Robert W

Co-Chief Executive Officer, Director, 10% OwnerSummit Therapeutics Inc. (SMMT) · full profile →Form 4 · filed Sep 11, 2025
Net Buying
Open-Market Buys
$6.0M
Open-Market Sells
$0
Net Open-Market Flow
$6.0M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 11, 2025Buy(P)5K$18.07$90K556.1M
Sep 10, 2025Buy(P)333K$17.68$5.9M556.1M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001599298-25-000142) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML